CURX: SEC Form S-8 filed by Curanex Pharmaceuticals Inc
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for CURX
Across the 8 sessions after earlier CURX headlines, the stock closed higher 6 times and lower 2 times, with a median move of 7.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CURX | SPY |
|---|---|---|---|
| Apr 8, 2026 | Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline | +3.0% | +2.5% |
| Apr 6, 2026 | Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care | +7.9% | +0.5% |
| Mar 18, 2026 | Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission | +10.4% | -1.4% |
| Mar 12, 2026 | Curanex Expands Scientific Advisory Board With Two Distinguished Researchers | -11.6% | -1.5% |
| Mar 11, 2026 | Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board | +6.1% | -0.1% |
| Mar 5, 2026 | Curanex Forms World Class Scientific Advisory Board | -5.0% | -0.6% |
Quantisnow market dataNASDAQ
CURX
Curanex Pharmaceuticals Inc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2025
Get push alerts for CURX
Full CURX profile on Quantisnow Follow CURX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time